Does bleeding affect patient‐reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review

Does bleeding affect patient‐reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review

Background Relatively minor bleeding (e.g., bruising and/or petechiae) may cause patient distress. This systematic review's objective was to assess whether bleeding affects health‐related quality of life (HRQoL) or illness perceptions or representations (IPs) in patients with hematologic malign...

書目詳細資料
Main Authors:	Estcourt, L, Pinchon, D, Symington, E, Kelly, A, Doree, C, Brunskill, S, Glidewell, L, Stanworth, S
格式:	Journal article
語言:	English
出版:	Wiley 2014

相似書籍

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
由: Estcourt, L, et al.
出版: (2017)

Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
由: Stanworth, S, et al.
出版: (2015)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
由: Wardrop, D, et al.
出版: (2013)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
由: Stanworth, S, et al.
出版: (2014)

Observational study of alternative platelet parameters to predict bleeding risk in patients with hematological malignancies (ATHENA study)
由: Estcourt, L, et al.
出版: (2013)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
由: Stanworth, S, et al.
出版: (2014)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
由: Wardrop, D, et al.
出版: (2016)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
由: Butler, C, et al.
出版: (2011)

Pathogen-reduced platelets for the prevention of bleeding.
由: Butler, C, et al.
出版: (2013)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
由: Stanworth, S, et al.
出版: (2006)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
由: Estcourt, L, et al.
出版: (2016)

Pathogen-reduced platelets for the prevention of bleeding (Review)
由: Butler, C, et al.
出版: (2013)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures
由: Huber, J, et al.
出版: (2019)

Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes?
由: Trivella, M, et al.
出版: (2019)

Platelet transfusions for patients with haematological malignancies: who needs them?
由: Estcourt, L, et al.
出版: (2011)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
由: Estcourt, L, et al.
出版: (2014)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
由: Estcourt, L, et al.
出版: (2012)

Transfusion Thresholds in Hematologic Malignancy Receiving Intensive Therapies - Risk of bias assessment
由: Estcourt, L
出版: (2023)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
由: Estcourt, L, et al.
出版: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
由: Estcourt, L, et al.
出版: (2014)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
由: Huber, J, et al.
出版: (2018)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
由: Estcourt, L, et al.
出版: (2014)

Hematologic malignancies : myelodysplastic syndromes /
由: Deeg, H. Joachim (Hans Joachim), 1945-
出版: (2006)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
由: Estcourt, L, et al.
出版: (2016)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
由: Estcourt, L, et al.
出版: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
由: Estcourt, L, et al.
出版: (2014)

Pathogen-reduced platelets for the prevention of bleeding (Review)
由: Estcourt, L, et al.
出版: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
由: Crighton, GL, et al.
出版: (2015)

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders
由: Gu, Y, et al.
出版: (2015)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
由: Estcourt, L, et al.
出版: (2017)

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders (Protocol)
由: Gu, Y, et al.
出版: (2015)

Persistent malignant stem cells in del(5q) myelodysplasia in remission.
由: Tehranchi, R, et al.
出版: (2010)

Risk factors for haemorrhage in patients with haematological malignancies
由: Estcourt, LJ
出版: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
由: Estcourt, L, et al.
出版: (2014)

Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial
由: Craddock, C, et al.
出版: (2016)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
由: Estcourt, L, et al.
出版: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
由: Estcourt, L, et al.
出版: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
由: Estcourt, L, et al.
出版: (2013)

Modeling hematologic malignancies and their treatment in humanized mice
由: Leskov, Ilya, Ph. D. Massachusetts Institute of Technology
出版: (2011)

Analysis of Current Patterns of Utilisation of Platelet Transfusion Components in Hematology Patients
由: Estcourt, L, et al.
出版: (2011)